Market Closed -
NSE India S.E.
07:40:29 2024-07-05 am EDT
|
5-day change
|
1st Jan Change
|
55.91
INR
|
+1.01%
|
|
+1.19%
|
-1.74%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,784
|
4,818
|
1,892
|
6,839
|
10,663
|
12,795
|
Enterprise Value (EV)
1 |
14,883
|
11,478
|
7,406
|
11,856
|
15,097
|
16,194
|
P/E ratio
|
-33.6
x
|
-113
x
|
-6.46
x
|
180
x
|
10.8
x
|
6.67
x
|
Yield
|
-
|
-
|
-
|
-
|
0.98%
|
1.15%
|
Capitalization / Revenue
|
0.57
x
|
0.36
x
|
0.15
x
|
0.47
x
|
0.43
x
|
0.49
x
|
EV / Revenue
|
1.25
x
|
0.85
x
|
0.58
x
|
0.81
x
|
0.62
x
|
0.61
x
|
EV / EBITDA
|
11.8
x
|
6.4
x
|
4.46
x
|
5.68
x
|
4.5
x
|
3.68
x
|
EV / FCF
|
-93.3
x
|
6.44
x
|
11.3
x
|
22.3
x
|
-62.1
x
|
115
x
|
FCF Yield
|
-1.07%
|
15.5%
|
8.85%
|
4.48%
|
-1.61%
|
0.87%
|
Price to Book
|
1.07
x
|
0.76
x
|
0.28
x
|
1
x
|
1.33
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
220,987
|
220,987
|
261,030
|
261,030
|
261,030
|
295,155
|
Reference price
2 |
30.70
|
21.80
|
7.250
|
26.20
|
40.85
|
43.35
|
Announcement Date
|
5/29/18
|
9/6/19
|
12/4/20
|
9/4/21
|
9/3/22
|
9/6/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
11,874
|
13,528
|
12,773
|
14,643
|
24,547
|
26,338
|
EBITDA
1 |
1,263
|
1,794
|
1,660
|
2,088
|
3,353
|
4,401
|
EBIT
1 |
385.5
|
960.2
|
794.4
|
1,220
|
2,480
|
3,519
|
Operating Margin
|
3.25%
|
7.1%
|
6.22%
|
8.33%
|
10.1%
|
13.36%
|
Earnings before Tax (EBT)
1 |
-490.9
|
-218.6
|
-396.6
|
136.8
|
1,432
|
2,744
|
Net income
1 |
-202
|
-42.7
|
-267.6
|
37.93
|
1,075
|
1,920
|
Net margin
|
-1.7%
|
-0.32%
|
-2.1%
|
0.26%
|
4.38%
|
7.29%
|
EPS
2 |
-0.9142
|
-0.1932
|
-1.123
|
0.1453
|
3.780
|
6.500
|
Free Cash Flow
1 |
-159.5
|
1,781
|
655.7
|
531.6
|
-243.3
|
140.6
|
FCF margin
|
-1.34%
|
13.16%
|
5.13%
|
3.63%
|
-0.99%
|
0.53%
|
FCF Conversion (EBITDA)
|
-
|
99.28%
|
39.49%
|
25.46%
|
-
|
3.19%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
1,401.42%
|
-
|
7.32%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
0.4000
|
0.5000
|
Announcement Date
|
5/29/18
|
9/6/19
|
12/4/20
|
9/4/21
|
9/3/22
|
9/6/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
8,099
|
6,661
|
5,514
|
5,017
|
4,434
|
3,399
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.41
x
|
3.713
x
|
3.32
x
|
2.403
x
|
1.322
x
|
0.7723
x
|
Free Cash Flow
1 |
-160
|
1,781
|
656
|
532
|
-243
|
141
|
ROE (net income / shareholders' equity)
|
-3.13%
|
-0.67%
|
-4.09%
|
0.56%
|
14.4%
|
21%
|
ROA (Net income/ Total Assets)
|
1.25%
|
3.22%
|
2.7%
|
4.11%
|
8.21%
|
11.1%
|
Assets
1 |
-16,166
|
-1,324
|
-9,899
|
922.3
|
13,102
|
17,311
|
Book Value Per Share
2 |
28.70
|
28.60
|
26.00
|
26.30
|
30.70
|
34.70
|
Cash Flow per Share
2 |
0.1600
|
0.0500
|
0.1300
|
1.920
|
3.360
|
0.3400
|
Capex
1 |
204
|
314
|
157
|
179
|
384
|
862
|
Capex / Sales
|
1.72%
|
2.32%
|
1.23%
|
1.22%
|
1.57%
|
3.27%
|
Announcement Date
|
5/29/18
|
9/6/19
|
12/4/20
|
9/4/21
|
9/3/22
|
9/6/23
|
|
1st Jan change
|
Capi.
|
---|
| -1.74% | 196M | | +20.09% | 67.35B | | -5.30% | 46.44B | | +22.19% | 44.28B | | +36.70% | 29.14B | | +11.89% | 19.48B | | +14.26% | 17.17B | | -25.77% | 15.04B | | -14.93% | 14.72B | | -31.27% | 12.07B |
Other Specialty Chemicals
|